BIOMAT Database Logo BIOMAT Database Logo

Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress. 2018

Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
a Environmental Physiology Lab , Department of Biomedical Sciences , University of Padova , Padua , Italy.

Early stages of avascular necrosis of the femoral head (AVNFH) can be conservatively treated with hyperbaric oxygen therapy (HBOT). This study investigated how HBOT modulates inflammatory markers and reactive oxygen species (ROS) in patients with AVNFH. Twenty-three male patients were treated with two cycles of HBOT, 30 sessions each with a 30 days break between cycles. Each session consisted of 90 minutes of 100% inspired oxygen at 2.5 absolute atmospheres of pressure. Plasma levels of tumor necrosis factor alfa (TNF-α), interleukin 6 (IL-6), interleukin 1 beta (IL-1β) and ROS production were measured before treatment (T0), after 15 and 30 HBOT sessions (T1 and T2), after the 30-day break (T3), and after 60 sessions (T4). Results showed a significant reduction in TNF-α and IL-6 plasma levels over time. This decrease in inflammatory markers mirrored observed reductions in bone marrow edema and reductions in patient self-reported pain.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005271 Femur Head Necrosis Aseptic or avascular necrosis of the femoral head. The major types are idiopathic (primary), as a complication of fractures or dislocations, and LEGG-CALVE-PERTHES DISEASE. Aseptic Necrosis of Femur Head,Avascular Necrosis of Femur Head,Necrosis, Aseptic, of Femur Head,Necrosis, Avascular, of Femur Head,Avascular Necrosis Of Femoral Head, Primary,Femoral Head, Avascular Necrosis Of,Ischemic Necrosis Of Femoral Head,Femur Head Necroses,Head Necrosis, Femur,Necrosis, Femur Head
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006931 Hyperbaric Oxygenation The therapeutic intermittent administration of oxygen in a chamber at greater than sea-level atmospheric pressures (three atmospheres). It is considered effective treatment for air and gas embolisms, smoke inhalation, acute carbon monoxide poisoning, caisson disease, clostridial gangrene, etc. (From Segen, Dictionary of Modern Medicine, 1992). The list of treatment modalities includes stroke. Oxygenation, Hyperbaric,Hyperbaric Oxygen Therapy,Hyperbaric Oxygen Therapies,Hyperbaric Oxygenations,Oxygen Therapies, Hyperbaric,Oxygen Therapy, Hyperbaric,Oxygenations, Hyperbaric,Therapies, Hyperbaric Oxygen,Therapy, Hyperbaric Oxygen
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
Hyperbaric Oxygen Therapy Ameliorates Sperm Parameters in Apolipoprotein E Knockout Mice Testes by Attenuating Oxidative Stress and Inflammation.
July 2023, Reproductive sciences (Thousand Oaks, Calif.),
Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
Hyperbaric oxygen therapy ameliorates intestinal and systematic inflammation by modulating dysbiosis of the gut microbiota in Crohn's disease.
May 2024, Journal of translational medicine,
Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
Hyperbaric oxygen therapy and osteonecrosis.
March 2017, Oral diseases,
Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
Hyperbaric Oxygen Therapy Counters Oxidative Stress/Inflammation-Driven Symptoms in Long COVID-19 Patients: Preliminary Outcomes.
September 2023, Metabolites,
Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
Reactive oxygen species, oxidative stress, glaucoma and hyperbaric oxygen therapy.
January 2018, Journal of optometry,
Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
Hyperbaric oxygen therapy ameliorates stress-impaired dermal wound healing.
May 2005, Brain, behavior, and immunity,
Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
Oxidative stress is fundamental to hyperbaric oxygen therapy.
March 2009, Journal of applied physiology (Bethesda, Md. : 1985),
Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
Activation of Farnesoid X Receptor by Schaftoside Ameliorates Acetaminophen-Induced Hepatotoxicity by Modulating Oxidative Stress and Inflammation.
July 2020, Antioxidants & redox signaling,
Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
Cyanidin ameliorates endotoxin-induced myocardial toxicity by modulating inflammation and oxidative stress through mitochondria and other factors.
October 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Gerardo Bosco, and Giuliano Vezzani, and Simona Mrakic Sposta, and Alex Rizzato, and Garrett Enten, and Abdullah Abou-Samra, and Sandro Malacrida, and Silvia Quartesan, and Alessandra Vezzoli, and Enrico Camporesi
Fraxin Ameliorates Ulcerative Colitis by Modulating Oxidative Stress, Inflammation and TLR4/NF-κB and MAPK Signaling Pathways.
March 2024, Alternative therapies in health and medicine,
Copied contents to your clipboard!